v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total Harrow, Inc. Stockholders’ Equity
Total Noncontrolling Interest Equity
Beginning balance at Dec. 31, 2024 $ 69,297,000 $ 35,000 $ 221,002,000 $ (151,385,000) $ 69,652,000 $ (355,000)
Beginning balance (in shares) at Dec. 31, 2024   35,622,214        
Issuance of common stock in connection with:            
Exercise of employee stock-based options 125,000   125,000   125,000  
Exercise of employee stock-based options (in shares)   10,618        
Vesting of RSUs 0 $ 2,000 (2,000)      
Vesting of RSUs (in shares)   1,634,009        
Shares withheld related to net share settlement of equity awards (12,769,000) $ (1,000) (12,768,000)   (12,769,000)  
Shares withheld related to net share settlement of equity awards (in shares)   (552,162)        
Stock-based compensation expense 5,431,000   5,431,000   5,431,000  
Net income (loss) (12,785,000)   0 (12,785,000) (12,785,000)  
Ending balance at Jun. 30, 2025 49,299,000 $ 36,000 213,788,000 (164,170,000) 49,654,000 (355,000)
Ending balance (in shares) at Jun. 30, 2025   36,714,679        
Beginning balance at Mar. 31, 2025 56,096,000 $ 35,000 225,581,000 (169,165,000) 56,451,000 (355,000)
Beginning balance (in shares) at Mar. 31, 2025   35,654,171        
Issuance of common stock in connection with:            
Exercise of employee stock-based options 102,000   102,000   102,000  
Exercise of employee stock-based options (in shares)   7,875        
Vesting of RSUs 0 $ 2,000 (2,000)      
Vesting of RSUs (in shares)   1,604,795        
Shares withheld related to net share settlement of equity awards (12,769,000) $ (1,000) (12,768,000)   (12,769,000)  
Shares withheld related to net share settlement of equity awards (in shares)   (552,162)        
Stock-based compensation expense 875,000   875,000   875,000  
Net income (loss) 4,995,000   0 4,995,000 4,995,000  
Ending balance at Jun. 30, 2025 49,299,000 $ 36,000 213,788,000 (164,170,000) 49,654,000 (355,000)
Ending balance (in shares) at Jun. 30, 2025   36,714,679        
Beginning balance at Dec. 31, 2025 52,091,000 $ 37,000 208,933,000 (156,524,000) 52,446,000 (355,000)
Beginning balance (in shares) at Dec. 31, 2025   37,229,159        
Issuance of common stock in connection with:            
Exercise of employee stock-based options 1,102,000   1,102,000   1,102,000  
Exercise of employee stock-based options (in shares)   265,094        
Vesting of RSUs 0 $ 0 0      
Vesting of RSUs (in shares)   20,500        
Shares withheld related to net share settlement of equity awards (1,101,000) $ 0 (1,101,000)   (1,101,000)  
Shares withheld related to net share settlement of equity awards (in shares)   (30,520)        
Stock-based compensation expense 7,625,000   7,625,000   7,625,000  
Net income (loss) (44,872,000)   0 (44,872,000) (44,872,000)  
Ending balance at Jun. 30, 2026 14,845,000 $ 37,000 216,559,000 (201,396,000) 15,200,000 (355,000)
Ending balance (in shares) at Jun. 30, 2026   37,484,233        
Beginning balance at Mar. 31, 2026 28,351,000 $ 37,000 212,795,000 (184,126,000) 28,706,000 (355,000)
Beginning balance (in shares) at Mar. 31, 2026   37,269,400        
Issuance of common stock in connection with:            
Exercise of employee stock-based options 1,077,000   1,077,000   1,077,000  
Exercise of employee stock-based options (in shares)   224,853        
Vesting of RSUs 0 $ 0 0      
Vesting of RSUs (in shares)   20,500        
Shares withheld related to net share settlement of equity awards (1,101,000) $ 0 (1,101,000)   (1,101,000)  
Shares withheld related to net share settlement of equity awards (in shares)   (30,520)        
Stock-based compensation expense 3,788,000   3,788,000   3,788,000  
Net income (loss) (17,270,000)   0 (17,270,000) (17,270,000)  
Ending balance at Jun. 30, 2026 $ 14,845,000 $ 37,000 $ 216,559,000 $ (201,396,000) $ 15,200,000 $ (355,000)
Ending balance (in shares) at Jun. 30, 2026   37,484,233